1. Anderson KO, Green CR, Payne R. Racial and ethnic disparities in pain: causes and consequences of unequal care. J Pain 2009;10:1187-1204.

2. Hoffman KM, Trawalter S, Axt JR, Oliver MN. Racial bias in pain assessment and treatment recommendations, and false beliefs about biological differences between blacks and whites. Proc Natl Acad Sci U S A 2016;113:4296-4301.

3. Lee P, Le Saux M, Siegel R, et al. Racial and ethnic disparities in the management of acute pain in US emergency departments: meta-analysis and systematic review. Am J Emerg Med 2019;37:1770-1777.

4. Pletcher MJ, Kertesz SG, Kohn MA, Gonzales R. Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. JAMA 2008;299:70-78.

5. Singhal A, Tien Y-Y, Hsia RY. Racial-ethnic disparities in opioid prescriptions at emergency department visits for conditions commonly associated with prescription drug abuse. PLoS One 2016;11(8):e0159224-e0159224.

6. Ly DP. Racial and ethnic disparities in the evaluation and management of pain in the outpatient setting, 2006-2015. Pain Med 2019;20:223-232.

7. Staton LJ, Panda M, Chen I, et al. When race matters: disagreement in pain perception between patients and their physicians in primary care. J Natl Med Assoc 2007;99:532-538.

8. Morasco BJ, Duckart JP, Carr TP, Deyo RA, Dobscha SK. Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain. Pain 2010;151:625-632.

9. Olsen Y, Daumit GL, Ford DE. Opioid prescriptions by U.S. primary care physicians from 1992 to 2001. J Pain 2006;7:225-235.

10. Hausmann LRM, Gao S, Lee ES, Kwoh KC. Racial disparities in the monitoring of patients on chronic opioid therapy. Pain 2013;154:46-52.

11. Joynt M, Train MK, Robbins BW, Halterman JS, Caiola E, Fortuna RJ. The impact of neighborhood socioeconomic status and race on the prescribing of opioids in emergency departments throughout the United States. J Gen Intern Med 2013;28:1604-1610.

12. Wisniewski AM, Purdy CH, Blondell RD. The epidemiologic association between opioid prescribing, non-medical use, and emergency department visits. J Addict Dis 2008;27:1-11.

13. Todd KH, Deaton C, D’Adamo AP, Goe L. Ethnicity and analgesic practice. Ann Emerg Med 2000;35:11-16.

14. Romanelli RJ, Shen Z, Szwerinski N, Scott A, Lockhart S, Pressman AR. Racial and ethnic disparities in opioid prescribing for long bone fractures at discharge from the emergency department: a cross-sectional analysis of 22 centers from a health care delivery system in northern California. Ann Emerg Med 2019;74:622-631.

15. Harrison JM, Lagisetty P, Sites BD, Guo C, Davis MA. Trends in prescription pain medication use by race/ethnicity among US adults with noncancer pain, 2000-2015. Am J Public Health 2018;108:788-790.

16. Cintron A, Morrison RS. Pain and ethnicity in the United States: a systematic review. J Palliat Med 2006;9:1454-1473.

17. Bleich SN, Findling MG, Casey LS, et al. Discrimination in the United States: experiences of Black Americans. Health Serv Res 2019;54:Suppl 2:1399-1408.

18. Soares WE III, Knowles KJ II, Friedmann PD. A thousand cuts: racial and ethnic disparities in emergency medicine. Med Care 2019;57:921-923.

19. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain — United States, 2016. MMWR Recomm Rep 2016;65:1-49.

20. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med 2003;349:1943-1953.

21. Barnett ML. Opioid prescribing in the midst of crisis — myths and realities. N Engl J Med 2020;382:1086-1088.

22. Dart RC, Severtson SG, Bucher-Bartelson B. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med 2015;372:1573-1574.

23. Lippold KM, Jones CM, Olsen EO, Giroir BP. Racial/ethnic and age group differences in opioid and synthetic opioid-involved overdose deaths among adults aged ≥18 years in metropolitan areas — United States, 2015–2017. MMWR Morb Mortal Wkly Rep 2019;68:967-973.

24. Bohnert AS, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011;305:1315-1321.

25. Frakt A, Monkovic T. A ‘rare case where racial biases’ protected African-Americans. New York Times. November 25, 2019 (https://www.nytimes.com/2019/11/25/upshot/opioid-epidemic-blacks.html).

26. Cleeland CS, Gonin R, Baez L, Loehrer P, Pandya KJ. Pain and treatment of pain in minority patients with cancer: the Eastern Cooperative Oncology Group Minority Outpatient Pain Study. Ann Intern Med 1997;127:813-816.

27. Frantsve LME, Kerns RD. Patient-provider interactions in the management of chronic pain: current findings within the context of shared medical decision making. Pain Med 2007;8:25-35.

28. Meara E, Horwitz JR, Powell W, et al. State legal restrictions and prescription-opioid use among disabled adults. N Engl J Med 2016;375:44-53.

29. Research Triangle Institute (RTI) race code. Research Data Assistance Center (https://www.resdac.org/cms-data/variables/research-triangle-institute-rti-race-code).

30. Narcotic equivalence converter. 2001 (http://www.medcalc.com/narcotics.html).

31. Opioid dose calculator. Olympia, WA: Agency Medical Directors’ Group, 2015 (http://agencymeddirectors.wa.gov/Calculator/DoseCalculator.htm).

32. Part D pharmacy characteristics file. Research Data Assistance Center (https://www.resdac.org/cms-data/files/part-d-pharmacy-characteristics).

33. Risk adjustment. 2016 model software (https://www.cms.gov/Medicare/Health-Plans/MedicareAdvtgSpecRateStats/Downloads/2016-Midyear-Final-Model.zip).

34. Data collection and monitoring. In: Smedley BD, Stith AY, Nelson AR, eds. Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Unequal treatment: confronting racial and ethnic disparities in health care. Washington, DC: National Academies Press, 2003:215-234.

35. Cohen GR, Jones DJ, Heeringa J, et al. Leveraging diverse data sources to identify and describe U.S. health care delivery systems. EGEMS (Wash DC) 2017;5:9-9.

36. Compendium of U.S. health systems, 2018. Rockville, MD: Agency for Healthcare Research and Quality, 2019 (https://www.ahrq.gov/chsp/data-resources/compendium-2018.html).

37. Centers for Medicare and Medicaid Services. Medicare Shared Savings Program: shared savings and losses and assignment methodology. Version 7. February 2019 (https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/Downloads/Shared-Savings-Losses-Assignment-Spec-V7.pdf).

38. CMS cell size suppression policy. Research Data Assistance Center, 2017 (https://resdac.org/articles/cms-cell-size-suppression-policy#:~:text=The%20policy%20stipulates%20that%20no,the%20minimum%20cell%20size%20policy).

39. Sabin J, Nosek BA, Greenwald A, Rivara FP. Physicians’ implicit and explicit attitudes about race by MD race, ethnicity, and gender. J Health Care Poor Underserved 2009;20:896-913.

40. Chapman EN, Kaatz A, Carnes M. Physicians and implicit bias: how doctors may unwittingly perpetuate health care disparities. J Gen Intern Med 2013;28:1504-1510.

41. Santoro TN, Santoro JD. Racial bias in the US opioid epidemic: a review of the history of systemic bias and implications for care. Cureus 2018;10(12):e3733-e3733.

42. Diversity in medicine: facts and figures 2019. Washington, DC: Association of American Medical Colleges, 2019 (https://www.aamc.org/data-reports/workforce/interactive-data/figure-18-percentage-all-active-physicians-race/ethnicity-2018).

43. Cooper LA, Roter DL, Johnson RL, Ford DE, Steinwachs DM, Powe NR. Patient-centered communication, ratings of care, and concordance of patient and physician race. Ann Intern Med 2003;139:907-915.

44. Todd KH, Samaroo N, Hoffman JR. Ethnicity as a risk factor for inadequate emergency department analgesia. JAMA 1993;269:1537-1539.

45. Mende-Siedlecki P, Qu-Lee J, Backer R, Van Bavel JJ. Perceptual contributions to racial bias in pain recognition. J Exp Psychol Gen 2019;148:863-889.

46. Boyd RW, Lindo EG, Weeks LD, McLemore MR. On racism: a new standard for publishing on racial health inequities. Health Affairs Blog, July 2, 2020 (https://www.healthaffairs.org/do/10.1377/hblog20200630.939347/full/).

47. Qato DM, Daviglus ML, Wilder J, Lee T, Qato D, Lambert B. ‘Pharmacy deserts’ are prevalent in Chicago’s predominantly minority communities, raising medication access concerns. Health Aff (Millwood) 2014;33:1958-1965.

48. Ryvicker M, Sridharan S. Neighborhood environment and disparities in health care access among urban Medicare beneficiaries with diabetes: a retrospective cohort study. Inquiry 2018;55:46958018771414-46958018771414.

49. Jeffery MM, Hooten WM, Hess EP, et al. Opioid prescribing for opioid-naive patients in emergency departments and other settings: characteristics of prescriptions and association with long-term use. Ann Emerg Med 2018;71(3):326-336.e19.

50. Morden NE, Munson JC, Colla CH, et al. Prescription opioid use among disabled Medicare beneficiaries: intensity, trends, and regional variation. Med Care 2014;52:852-859.

51. Skinner J, Chandra A, Staiger D, Lee J, McClellan M. Mortality after acute myocardial infarction in hospitals that disproportionately treat black patients. Circulation 2005;112:2634-2641.

52. Bynum JPW, Fisher ES, Song Y, Skinner J, Chandra A. Measuring racial disparities in the quality of ambulatory diabetes care. Med Care 2010;48:1057-1063.